Latest Articles
-
Randomized Controlled Trial Comparative Study Clinical Trial Retracted Publication
Cardiovascular responses to tracheal extubation or LMA removal in children.
This study was designed to investigate the cardiovascular effects related to tracheal extubation or laryngeal mask airway (LMA) removal in children. ⋯ Laryngeal mask airway removal elicited less haemodynamic change than tracheal extubation in paediatric patients.
-
Intensive care medicine · Feb 1998
Retracted PublicationVolume replacement strategies on intensive care units: results from a postal survey.
To assess volume replacement strategies on intensive care units (ICUs) in Germany. ⋯ The kind of volume therapy differs widely among the different ICUs. This questionnaire supported the supposition that no standards exist for volume therapy in intensive care patients. New results concerning the abuse of albumin in the critically ill have not yet influenced strategies of volume replacement.
-
Intensive care medicine · Jan 1998
Randomized Controlled Trial Clinical Trial Retracted PublicationVolume therapy in the critically ill: is there a difference?
There are still several concerns about the extensive and prolonged use of hydroxyethylstarch solution (HES) in critically ill patients. The effects of volume replacement with HES over 5 days on hemodynamics, laboratory data, and organ function were compared with volume therapy using human albumin (HA). ⋯ Volume therapy with 10% HES for 5 days in the ICU patient showed no disadvantages compared with an infusion regimen using 20% albumin. Volume replacement using HES may even be associated with improved hemodynamics. HES appears to be a valuable and significantly cheaper alternative to albumin--even for prolonged volume therapy in the critically ill patient.
-
Retraction Of Publication
Hyperventilation in patients who have sustained myocardial infarction after a work injury.
-
Intensive care medicine · May 1997
Retracted PublicationDoes continuous heparinization influence platelet function in the intensive care patient?
To study the influence of continuous administration of heparin on platelet function in intensive care patients. ⋯ Continuous administration of heparin with an average dose of approximately 500 U/h did not negatively influence platelet function in the trauma patients. Recovery from reduced platelet function in the sepsis group was not affected by continuous heparinization. Thus, continuous heparinization with this dose appears to be safe with regard to platelet function in the intensive care patient.